← Leaderboards
Kenton James Johnston
Saint Louis University
$1,699,490
Attributed
$1,699,490
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $462.7K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,699,490 · 2
By mechanism
R01$1,391,190 · 1
R21$308,300 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “United States Centers For Medicare And Medicaid Services”
- Ying Xian · Ut Southwestern Medical Center$6,460,808
- Joe Lake · National Cancer Institute$4,020,000
- Wei-Hsuan Lo-Ciganic · University Of Florida$3,726,621
- Jiani Yu · University Of Minnesota$3,111,363
- Rishi Kumar Wadhera · Beth Israel Deaconess Medical Center$3,033,771
- Justin W. Timbie · Rand Corporation$3,019,786
Research focus
United States Centers For Medicare And Medicaid ServicesVirtualPhysiciansPerformanceProgramsSurveysOutpatientsMissionPatient PopulationPaymentDiagnosisEvidence BasePublic HealthRisk AdjustmentData CentersIncentivesMedicalMedicareCost OutcomesPatient-Focused OutcomesBeneficiaryCostCare CostsRetrospective Cohort Study
Grant awards (7)
Can the Medicare Quality Payment Program Incentivize Evidence-Based Treatment of Depression and Anxiety Disorders by Primary Care Providers?$307,410
R01 · FY2024 · MH · contact PI
Can the Medicare Quality Payment Program Incentivize Evidence-Based Treatment of Depression and Anxiety Disorders by Primary Care Providers?$323,624
R01 · FY2023 · MH · contact PI
Can the Medicare Quality Payment Program Incentivize Evidence-Based Treatment of Depression and Anxiety Disorders by Primary Care Providers?$439,006
R01 · FY2022 · MH · contact PI
Can the Medicare Quality Payment Program Incentivize Evidence-Based Treatment of Depression and Anxiety Disorders by Primary Care Providers?$321,150
R01 · FY2021 · MH · contact PI
The Effect of Patient Dementia on Outpatient Clinicians' Performance on Cost Outcomes Under Medicare Value-Based Payment.$113,888
R21 · FY2021 · AG · contact PI
The Effect of Patient Dementia on Outpatient Clinicians' Performance on Cost Outcomes Under Medicare$27,682
R21 · FY2021 · AG · contact PI
The Effect of Patient Dementia on Outpatient Clinicians' Performance on Cost Outcomes Under Medicare Value-Based Payment.$166,730
R21 · FY2020 · AG · contact PI